All patients with invasive cervical cancer should be followed up with Pap
smear every three months for two years after treatment, and then every six
months for the subsequent three years.
Patients who have a local recurrence can be treated with radiation therapy; if
they had received radiation previously, they might be considered candidates
for a pelvic exenteration.
Patients with distant metastases should be considered for chemotherapy
treatment. The most active chemotherapeutic agent for cervical cancer is
cisplatinum.